Neratinib for Extended Anti-HER2 Therapy in Early Breast Cancer

por Budd, G. Thomas, Vogel, Wendy H.
Publicado 2018

Hypercalcemia Caused by Metastatic Adamantinoma: Response to Radiotherapy

por Lyons, Janice A., Budd, G. Thomas, Crownover, Richard L.
Publicado 1999

Durable Near-Complete Response to Anti-PD-1 Checkpoint Immunotherapy in a Refractory Malignant Solitary Fibrous Tumor of the Pleura

por Boothe, James T., Budd, G. Thomas, Smolkin, Matthew B., Ma, Patrick C.
Publicado 2017

Phosphatase inhibitor, sodium stibogluconate, in combination with interferon (IFN) alpha 2b: phase I trials to identify pharmacodynamic and clinical effects

por Yi, Taolin, Elson, Paul, Mitsuhashi, Masato, Jacobs, Barbara, Hollovary, Emese, Budd, G. Thomas, Spiro, Timothy, Triozzi, Pierre, Borden, Ernest C.
Publicado 2011

Palindromic amplification of the ERBB2 oncogene in primary HER2-positive breast tumors

por Marotta, Michael, Onodera, Taku, Johnson, Jeffrey, Budd, G. Thomas, Watanabe, Takaaki, Cui, Xiaojiang, Giuliano, Armando E., Niida, Atsushi, Tanaka, Hisashi
Publicado 2017

MET and PTEN gene copy numbers and Ki-67 protein expression associate with pathologic complete response in ERBB2-positive breast carcinoma patients treated with neoadjuvant trastuz...

por Calhoun, Benjamin C., Portier, Bryce, Wang, Zhen, Minca, Eugen C., Budd, G. Thomas, Lanigan, Christopher, Tubbs, Raymond R., Morrison, Larry E.
Publicado 2016

HER4 expression status correlates with improved outcome in both neoadjuvant and adjuvant Trastuzumab treated invasive breast carcinoma

por Portier, Bryce P, Minca, Eugen C, Wang, Zhen, Lanigan, Christopher, Gruver, Aaron M, Downs-Kelly, Erinn, Budd, G Thomas, Tubbs, Raymond R
Publicado 2013

Impact of early detection on cancer curability: A modified Delphi panel study

por Schwartzberg, Lee, Broder, Michael S., Ailawadhi, Sikander, Beltran, Himisha, Blakely, L. Johnetta, Budd, G. Thomas, Carr, Laurie, Cecchini, Michael, Cobb, Patrick, Kansal, Anuraag, Kim, Ashley, Monk, Bradley J., Wong, Deborah J., Campos, Cynthia, Yermilov, Irina
Publicado 2022

Genetic variations that influence paclitaxel pharmacokinetics and intracellular effects that may contribute to chemotherapy-induced neuropathy: A narrative review

por Johnson, Ken B., Sharma, Anukriti, Henry, N. Lynn, Wei, Mei, Bie, Bihua, Hershberger, Courtney E., Rhoades, Emily E., Sen, Alper, Johnson, Ryan E., Steenblik, Jacob, Hockings, Jennifer, Budd, G. Thomas, Eng, Charis, Foss, Joseph, Rotroff, Daniel M.
Publicado 2023

The expression of TRMT2A, a novel cell cycle regulated protein, identifies a subset of breast cancer patients with HER2 over-expression that are at an increased risk of recurrence

por Hicks, David G, Janarthanan, Bagi R, Vardarajan, Ramya, Kulkarni, Swati A, Khoury, Thaer, Dim, Daniel, Budd, G Thomas, Yoder, Brian J, Tubbs, Raymond, Schreeder, Marshall T, Estopinal, Noel C, Beck, Rodney A, Wang, Yanling, Ring, Brian Z, Seitz, Robert S, Ross, Douglas T
Publicado 2010

Cardiac risk stratification in cancer patients: A longitudinal patient–patient network analysis

por Hou, Yuan, Zhou, Yadi, Hussain, Muzna, Budd, G. Thomas, Tang, Wai Hong Wilson, Abraham, James, Xu, Bo, Shah, Chirag, Moudgil, Rohit, Popovic, Zoran, Watson, Chris, Cho, Leslie, Chung, Mina, Kanj, Mohamed, Kapadia, Samir, Griffin, Brian, Svensson, Lars, Collier, Patrick, Cheng, Feixiong
Publicado 2021

Impact of timing of atrial fibrillation, CHA(2)DS(2)-VASc score and cancer therapeutics on mortality in oncology patients

por Hussain, Muzna, Misbah, Rabel, Donnellan, Eoin, Alkharabsheh, Saqer, Hou, Yuan, Cheng, Feixiong, Crookshanks, Michael, Watson, Chris J, Toth, Andrew J, Houghtaling, Penny, Moudgil, Rohit, Budd, G Thomas, Tang, W H Wilson, Kwon, Deborah H, Jaber, Wael, Griffin, Brian, Kanj, Mohamad, Collier, Patrick
Publicado 2020

Multicenter phase II trial (SWOG S1609, cohort 51) of ipilimumab and nivolumab in metastatic or unresectable angiosarcoma: a substudy of dual anti-CTLA-4 and anti-PD-1 blockade in...

por Wagner, Michael J, Othus, Megan, Patel, Sandip P, Ryan, Chris, Sangal, Ashish, Powers, Benjamin, Budd, G Thomas, Victor, Adrienne I, Hsueh, Chung-Tsen, Chugh, Rashmi, Nair, Suresh, Leu, Kirsten M, Agulnik, Mark, Sharon, Elad, Mayerson, Edward, Plets, Melissa, Blanke, Charles, Streicher, Howard, Chae, Young Kwang, Kurzrock, Razelle
Publicado 2021

Adherence to Cancer Prevention Lifestyle Recommendations Before, During, and 2 Years After Treatment for High-risk Breast Cancer

por Cannioto, Rikki A., Attwood, Kristopher M., Davis, Evan W., Mendicino, Lucas A., Hutson, Alan, Zirpoli, Gary R., Tang, Li, Nair, Nisha M., Barlow, William, Hershman, Dawn L., Unger, Joseph M., Moore, Halle C. F., Isaacs, Claudine, Hobday, Timothy J., Hortobagyi, Gabriel N., Gralow, Julie R., Albain, Kathy S., Budd, G. Thomas, Ambrosone, Christine B.
Publicado 2023

Germline genetic variants in ABCB1, ABCC1, and ALDH1A1 and risk of hematological and gastrointestinal toxicities in a SWOG Phase III trial S0221 for breast cancer

por Yao, Song, Sucheston, Lara E., Zhao, Hua, Barlow, William E., Zirpoli, Gary, Liu, Song, Moore, Halle C.F., Budd, G. Thomas, Hershman, Dawn L., Davis, Warren, Ciupak, Gregory L., Stewart, James A., Isaacs, Claudine, Hobday, Timothy J., Salim, Muhammad, Hortobagyi, Gabriel N., Gralow, Julie R., Livingston, Robert B., Albain, Kathy S., Hayes, Daniel F., Ambrosone, Christine B.
Publicado 2013

Randomized phase II trial of fulvestrant alone or in combination with bortezomib in hormone receptor-positive metastatic breast cancer resistant to aromatase inhibitors: a New York...

por Adelson, Kerin, Ramaswamy, Bhuvaneswari, Sparano, Joseph A, Christos, Paul J, Wright, John J, Raptis, George, Han, Gang, Villalona-Calero, Miguel, Ma, Cynthia X, Hershman, Dawn, Baar, Joseph, Klein, Paula, Cigler, Tessa, Budd, G Thomas, Novik, Yelena, Tan, Antoinette R, Tannenbaum, Susan, Goel, Anupama, Levine, Ellis, Shapiro, Charles L, Andreopoulou, Eleni, Naughton, Michael, Kalinsky, Kevin, Waxman, Sam, Germain, Doris
Publicado 2016

Ki67 Proliferation Index as a Tool for Chemotherapy Decisions During and After Neoadjuvant Aromatase Inhibitor Treatment of Breast Cancer: Results From the American College of Surg...

por Ellis, Matthew J., Suman, Vera J., Hoog, Jeremy, Goncalves, Rodrigo, Sanati, Souzan, Creighton, Chad J., DeSchryver, Katherine, Crouch, Erika, Brink, Amy, Watson, Mark, Luo, Jingqin, Tao, Yu, Barnes, Michael, Dowsett, Mitchell, Budd, G. Thomas, Winer, Eric, Silverman, Paula, Esserman, Laura, Carey, Lisa, Ma, Cynthia X., Unzeitig, Gary, Pluard, Timothy, Whitworth, Pat, Babiera, Gildy, Guenther, J. Michael, Dayao, Zoneddy, Ota, David, Leitch, Marilyn, Olson, John A., Allred, D. Craig, Hunt, Kelly
Publicado 2017